Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Korean Coronary Bifurcation Stenting (COBIS) Registry II

This study has been completed.
Information provided by (Responsible Party):
Hyeon-Cheol Gwon, Samsung Medical Center Identifier:
First received: July 15, 2012
Last updated: January 9, 2013
Last verified: January 2013

The COBIS II registry is a multi-center, real-world registry of drug-eluting stenting in coronary bifurcation lesions in South Korea. From 18 major coronary intervention centers in Korea, a total of 2,873 patients were enrolled in this database between January 2003 and December 2009.

The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with drug-eluting stents for coronary bifurcation lesions in South Korea.

Coronary Bifurcation Lesion

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Korean Coronary Bifurcation Stenting (COBIS) Registry II

Further study details as provided by Hyeon-Cheol Gwon, Samsung Medical Center:

Primary Outcome Measures:
  • Incidence of the composite outcomes of cardiac death, target vessel-related myocardial infarction, or target-lesion revascularization [ Time Frame: 3 years ]

Secondary Outcome Measures:
  • Cardiac death [ Time Frame: 3 years ]
  • Myocardial infarction [ Time Frame: 3 years ]
  • Target lesion revascularization [ Time Frame: 3 years ]
  • Stent thrombosis [ Time Frame: 3 years ]

Enrollment: 2873
Study Start Date: January 2011
Study Completion Date: April 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Coronary bifurcation lesion


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with coronary bifurcation lesion treated with drug-eluting stents

Inclusion Criteria:

  • Age >= 18 years
  • Any type of bifurcation lesion in major epicardial artery
  • Side branch reference diameter >= 2.3 mm and at least stentable with 2.5 mm stent
  • Treated with drug-eluting stent

Exclusion Criteria:

  • Protected left main disease previous CABG for LAD or LCX territory
  • Cardiogenic Shock
  • History of CPR in the same hospitalization
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01642992

Korea, Republic of
Samsung Medical Center
Seoul, Korea, Republic of, 135-710
Sponsors and Collaborators
Hyeon-Cheol Gwon
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Hyeon-Cheol Gwon, Professor, Samsung Medical Center Identifier: NCT01642992     History of Changes
Other Study ID Numbers: 2010-11-060
Study First Received: July 15, 2012
Last Updated: January 9, 2013

Keywords provided by Hyeon-Cheol Gwon, Samsung Medical Center:
Coronary bifurcation lesion
Drug-eluting stent processed this record on May 25, 2017